CorMatrix Cardiovascular, Inc. Receives core U.S. Patent for Injectable Biomaterial

8,568,761 for an augmented injectable extracellular matrix bioscaffold. The augmented ECM bioscaffold induces stem cell proliferation and differentiation of stem cells into cardiomyocytes, and, thereby, angiogenesis and remodeling, i.e. tissue repair, of cardiovascular tissue .

http://ift.tt/KHnJ4d